English | 简体中文 | 繁體中文 | 한국어
 English Press Releases
 Medicine BioTech
Avantor Recognized with Two Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2025
Mar 31, 2025 11:00 HKT
Revenue Soars with 137% Year-on-Year Growth, Multiple Products Poised for Launch, CanSinoBIO's Growth Momentum Strong
Mar 25, 2025 23:34 HKT
Sino Biopharm (1177.HK) Announces 2024 Annual Results
Mar 20, 2025 23:58 HKT
Gain Therapeutics Doses First Participant in Phase 1b Clinical Trial of GT-02287 in Parkinson's Disease
Mar 16, 2025 01:30 HKT
Everest Medicines Hits Three-Year High as AI+mRNA Pipeline Reshapes Valuation
Mar 07, 2025 19:30 HKT
Register Now: analytica Vietnam's Largest Edition & Must-See Innovations!
Mar 06, 2025 07:32 HKT
Micreos Pharmaceuticals Partners With Biologics CDMO Northway Biotech for Its Engineered Endolysin Therapeutic Manufacturing Program
Mar 04, 2025 20:00 HKT
HighTide Therapeutics Announces Publication of Phase 2 Study of Berberine Ursodeoxycholate for the Treatment of Type 2 Diabetes Mellitus in JAMA Network Open
Mar 04, 2025 12:26 HKT
Hua Medicine Awarded Shanghai Innovative Enterprise Headquarters
Mar 03, 2025 14:50 HKT
CGFNS International to Change Its Name to TruMerit
Feb 26, 2025 07:00 HKT
Goldman Sachs Raises Everest Medicines' Target Price to HK$48.32 on Stronger Commercial and R&D Outlook
Feb 19, 2025 14:42 HKT
CGFNS International Reports Nurse Migration Rates to the U.S. Remained High in 2024
Feb 12, 2025 08:00 HKT
An Incredible KLAS Triple-Award Win for AGFA HealthCare!
Feb 10, 2025 22:00 HKT
Mallia Therapeutics and Northway Biotech Announce Partnership for the Manufacturing of Soluble CD83 Protein for Hair Loss Treatment
Feb 04, 2025 18:00 HKT
Where is the next Chinese drug that will make MNCs compete to grab orders?
Jan 09, 2025 21:34 HKT
Biotech Startups Get a Boost: ZAGENO and Hatch.Bio Labs Partner to Streamline Lab Operations
Jan 08, 2025 22:30 HKT
Everest Medicines Announces the Implementation of NEFECON National Reimbursement Drug List Pricing in China for the Treatment for IgA Nephropathy
Jan 02, 2025 10:52 HKT
Everest Medicines Announces the First Prescription of VELSIPITY(R) in the Greater Bay Area
Dec 18, 2024 14:29 HKT
Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY
Dec 17, 2024 10:58 HKT
CIL Announces Breakthrough in Benzene Recovery, Addressing Cost, Environmental, and Supply Challenges for OLED Display Manufacturers
Dec 12, 2024 22:00 HKT
Next >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: